5 Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood, 1995, 86: 419-431
[6]
6 Kuter D J. New thrombopoietic growth factors. Clin Lymphoma Myeloma, 2009, 9: S347-S356？？
[7]
7 罗庆良, Neelis K J, Wagemaker G. 血小板生成素对猴急性放射病的治疗. 实验血液学杂志, 1996, 4: 324-327
[8]
8 Kuter D J. Biology and chemistry of thrombopoietic agents. Semin Hematol, 2010, 47: 243-248？？
[9]
9 Herodin F, Grenier N, Drouet M. Revisting therapeutic strategies in radiation casualties. Exp Hematol, 2007, 35: 28-33？？
[10]
10 Neelis K J, Visser T P, Dimjati W, et al. A single dose of thrombopoietin shortly after myelosuppressive total body irradiation preventspancytopenia in mice by promoting short-term multilineage spleen repopulating cells at the transient expense of bone marrow repopulatingcells. Blood, 1998, 92: 1586-1597
[11]
11 Mouthon M A, Gaugler M H, Van der Meeren A, et al. Single administration of thrombopoietin to lethally irradiated mice preventsinfectious and thrombotic events leading to mortality. Exp Hematol. 2001, 29: 30-40
13 罗庆良, Neelis K J, Wagemaker G. 重组人血小板生长因子和重组人粒细胞集落刺激因子对急性放射病猴的治疗作用. 中华放射医学与防护杂志, 1999, 19: 34-38
[14]
14 Ye J Y, Chan G C, Qiao L, et al. Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-inducedthrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway. Haematologica, 2010, 95:1745-1753？？
